Benign prostatic hyperplasia: Many new options, same old approach Steven A. Kaplan Editor’s Commentary Pages: 83 - 83
Induction of apoptosis in the prostate by α1-adrenoceptor antagonists: A novel effect of “Old” drugs Natasha KyprianouStephen C. Jacobs OriginalPaper Pages: 89 - 96
The clinical role of α-blockers in the treatment of benign prostatic hyperplasia Grenville M. OadesJonathan D. EatonRoger S. Kirby OriginalPaper Pages: 97 - 102
Phytotherapeutic agents in the treatment of benign prostatic hyperplasia Kurt Dreikorn OriginalPaper Pages: 103 - 109
Transurethral microwave thermotherapy in benign prostatic hyperplasia Pieter MinneeFrans M. J. DebruyneJean J. M. C. H. de la Rosette OriginalPaper Pages: 110 - 115
Transurethral vaporization of the prostate: Current techniques Mark A. CabelinAlexis E. TeSteven A. Kaplan OriginalPaper Pages: 116 - 123
The use of lasers in benign prostatic enlargement Tom A. McNicholasSadmeet Singh OriginalPaper Pages: 124 - 131
An evidence-based approach to the treatment of prostatitis: Is it possible? Andrew Doble OriginalPaper Pages: 142 - 147
α-Blockers: An effective treatment for prostatitis? David CaropresoTimothy D. Moon OriginalPaper Pages: 148 - 154
Pelvic floor physical therapy for patients with prostatitis Jeannette M. PottsElizabeth O’Dougherty OriginalPaper Pages: 155 - 158
